Calcium acetate assay in calcium acetate capsules
Applications | 2024 | MetrohmInstrumentation
Calcium acetate serves as a phosphate binder in the gastrointestinal tract, helping patients with kidney disease manage elevated phosphate levels.
Reliable and sensitive analytical methods are essential to ensure dosage accuracy and compliance with stringent pharmaceutical standards.
This study aimed to validate an ion chromatography (IC) assay for quantifying calcium in calcium acetate capsules in accordance with the U.S. Pharmacopeia monograph.
The focus was on establishing method performance parameters that meet USP <621> and <1225> requirements.
Standard and sample solutions were prepared by dissolving USP Calcium Acetate Reference Standard to produce a 0.08 mg/mL calibration solution and diluting capsule extracts to the same nominal concentration.
All solutions underwent sonication and filtration prior to analysis.
Chromatographic separation was performed on a Metrosep C 6 - 150/4.0 column using an eluent of 0.75 mmol/L dipicolinic acid and 1.7 mmol/L nitric acid at 0.9 mL/min and 35 °C, with a 40-minute run time.
Detection was achieved via non-suppressed conductivity.
The IC method demonstrated a clear calcium peak at 24 minutes with no interferences.
Column efficiency exceeded 5900 theoretical plates and repeatability (n=6) yielded an RSD of 0.4% (USP limit <2.0%).
Assay recovery was 102.6% of the labeled content, meeting the 90.0–110.0% acceptance range.
These results confirm compliance with USP criteria for precision, accuracy and efficiency.
This IC method offers enhanced sensitivity and selectivity over previous titration or LC-UV approaches.
Its robustness and alignment with USP standards make it well-suited for quality control in pharmaceutical manufacturing and laboratory environments.
Potential developments include further automation, integration of mass spectrometric detection for multi-ion analysis, and miniaturization of IC systems for high-throughput screening.
Broader adoption could extend to other mineral analysis in complex dosage forms.
The validated ion chromatography method meets USP requirements for calcium acetate assay and provides a reliable, precise, and efficient tool for pharmaceutical quality control.
Ion chromatography
IndustriesPharma & Biopharma
ManufacturerMetrohm
Summary
Significance of the Topic
Calcium acetate serves as a phosphate binder in the gastrointestinal tract, helping patients with kidney disease manage elevated phosphate levels.
Reliable and sensitive analytical methods are essential to ensure dosage accuracy and compliance with stringent pharmaceutical standards.
Objectives and Study Overview
This study aimed to validate an ion chromatography (IC) assay for quantifying calcium in calcium acetate capsules in accordance with the U.S. Pharmacopeia monograph.
The focus was on establishing method performance parameters that meet USP <621> and <1225> requirements.
Methodology and Instrumentation
Standard and sample solutions were prepared by dissolving USP Calcium Acetate Reference Standard to produce a 0.08 mg/mL calibration solution and diluting capsule extracts to the same nominal concentration.
All solutions underwent sonication and filtration prior to analysis.
Chromatographic separation was performed on a Metrosep C 6 - 150/4.0 column using an eluent of 0.75 mmol/L dipicolinic acid and 1.7 mmol/L nitric acid at 0.9 mL/min and 35 °C, with a 40-minute run time.
Detection was achieved via non-suppressed conductivity.
Applied Instrumentation
- Metrohm 919 IC Autosampler plus
- Metrohm 930 Compact IC Flex Oven/Deg
- Metrosep C 6 - 150/4.0 separation column (L76 packing)
- Non-suppressed conductivity detector
Main Results and Discussion
The IC method demonstrated a clear calcium peak at 24 minutes with no interferences.
Column efficiency exceeded 5900 theoretical plates and repeatability (n=6) yielded an RSD of 0.4% (USP limit <2.0%).
Assay recovery was 102.6% of the labeled content, meeting the 90.0–110.0% acceptance range.
These results confirm compliance with USP criteria for precision, accuracy and efficiency.
Benefits and Practical Applications
This IC method offers enhanced sensitivity and selectivity over previous titration or LC-UV approaches.
Its robustness and alignment with USP standards make it well-suited for quality control in pharmaceutical manufacturing and laboratory environments.
Future Trends and Applications
Potential developments include further automation, integration of mass spectrometric detection for multi-ion analysis, and miniaturization of IC systems for high-throughput screening.
Broader adoption could extend to other mineral analysis in complex dosage forms.
Conclusion
The validated ion chromatography method meets USP requirements for calcium acetate assay and provides a reliable, precise, and efficient tool for pharmaceutical quality control.
References
- Biruete A, Gallant KMH, Lindemann SR, et al. Phosphate Binders and Nonphosphate Effects in the Gastrointestinal Tract. Journal of Renal Nutrition. 2020;30(1):4–10.
- Sekar A, Kaur T, Nally JV, et al. Phosphorus Binders: The New and the Old, and How to Choose. Cleveland Clinic Journal of Medicine. 2018;85(8):629–638.
- U.S. Pharmacopeia. USP-NF Calcium Acetate Capsules Monograph. USP 44–NF 39.
- U.S. Pharmacopeia. General Chapter <621> Chromatography. USP 44–NF 39.
- U.S. Pharmacopeia. General Chapter <1225> Validation of Compendial Procedures. USP 44–NF 39.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Potassium assay in potassium citrate and citric acid oral solution
2024|Metrohm|Applications
Application Note AN-C-197 Potassium assay in potassium citrate and citric acid oral solution Method validation according to the U.S. Pharmacopeia (USP) Potassium citrate and citric acid oral solutions are the USP specifies ion chromatography using a cation- systemic alkalizers beneficial…
Key words
potassium, potassiumcitrate, citratecitric, citricoral, oralusp, uspacid, acidmonograph, monographconductivity, conductivitystone, stoneassay, assaysolution, solutionalkalizers, alkalizersperistaltic, peristalticsuppressed, suppressedcation
IC Assays for Calcium and Magnesium according to USP
|Metrohm|Applications
AN-C-194 IC Assays for Calcium and Magnesium according to USP Two method validations according to U.S. Pharmacopoeia Summary Calcium carbonate has a wide applicability in the pharmaceutical industry as an excipient and also as an active ingredient, and in the…
Key words
metrohm, metrohmcalcium, calciummagnesium, magnesiumconductivity, conductivitytablets, tabletsdescribe, describechewable, chewablecarbonate, carbonateassays, assayscompact, compactmagnesia, magnesiaintelligent, intelligentvalidated, validatedassay, assaywell
Fluoride in sodium fluoride tablets forpharmaceutical use
2023|Metrohm|Applications
Application Note AN-S-379 Fluoride in sodium fluoride tablets for pharmaceutical use Method qualification according to the U.S. Pharmacopeia Fluoride has been shown to be effective at preventing quality standards as given by the United States tooth decay and supporting remineralization…
Key words
fluoride, fluorideusp, uspsodium, sodiumpass, passtablets, tabletsconductivity, conductivitytooth, toothstandard, standardqualification, qualificationeluent, eluentsuppressed, suppressedapplying, applyingqualified, qualifiedacetate, acetateperistaltic
Potassium in potassium bicarbonate and potassium chloride effervescent tablets for oral solution
2023|Metrohm|Applications
Application Note AN-C-185 Potassium in potassium bicarbonate and potassium chloride effervescent tablets for oral solution Method validation according to the U.S. Pharmacopoeia Potassium bicarbonate and potassium chloride potassium bicarbonate and potassium chloride effervescent tablets for oral solution are used to…
Key words
potassium, potassiumbicarbonate, bicarbonateeffervescent, effervescentchloride, chlorideoral, oraltablets, tabletsusp, uspvalidated, validatedsolution, solutionmonograph, monographhypokalemia, hypokalemiaaccording, accordingcations, cationscontent, contentapproved
